본문 바로가기
KERD
논문KCI 등재

스타틴으로 조절되지 않는 이상지질혈증 환자에게 대시호탕 복용이 미치는 영향

A Retrospective Study on the Effect of Daeshiho-tang on the Lipid Profile in Patients with Uncontrolled Dyslipidemia by Statins

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective: This study was conducted to investigate the lipid-lowering effect and safety of Daeshiho-tang in patients with uncontrolled lipid levels by statins. Methods: We investigated patients who had an abnormal lipid profile even when taking statins and who were administered Daeshiho-tang at Kyung-Hee University Korean Medical Hospital for at least one day between January 2008 and December 2018. Their basal characteristics and examinations were reviewed retrospectively with respect to lipid profile, AST, ALT, GGT, BUN, and creatinine. The lipid profile was composed of total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol. Subgroup analysis was performed on each component of dyslipidemia. Results: Among 20 participants, there were 10 males and 10 females. The mean BMI was 23.52. Eighty five percent of the participants were diagnosed as having cerebral infarction. After the administration of Daeshiho-tang, total cholesterol and LDL cholesterol were significantly reduced, to 41.3 mg/dl and 33.95 mg/dl, respectively. In subgroup analyses, total cholesterol and LDL cholesterol were significantly decreased, to 63 mg/dl and 54.6 mg/dl, respectively. Liver and kidney function showed no significant difference after taking Daeshiho-tang. Conclusions: Daeshiho-tang as a decoction or powder had significant lipid-lowering effects on total cholesterol and LDL cholesterol in patients with dyslipidemia. The lipid-lowering effect on total and LDL cholesterol increased in patients with hypercholesterolemia and hyper-LDL-cholesterolemia, respectively. Based on the minimal changes in the liver and kidney function test, Daeshiho-tang would be safe enough to be used in clinics.

Abstract

Objective: This study was conducted to investigate the lipid-lowering effect and safety of Daeshiho-tang in patients with uncontrolled lipid levels by statins. Methods: We investigated patients who had an abnormal lipid profile even when taking statins and who were administered Daeshiho-tang at Kyung-Hee University Korean Medical Hospital for at least one day between January 2008 and December 2018. Their basal characteristics and examinations were reviewed retrospectively with respect to lipid profile, AST, ALT, GGT, BUN, and creatinine. The lipid profile was composed of total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol. Subgroup analysis was performed on each component of dyslipidemia. Results: Among 20 participants, there were 10 males and 10 females. The mean BMI was 23.52. Eighty five percent of the participants were diagnosed as having cerebral infarction. After the administration of Daeshiho-tang, total cholesterol and LDL cholesterol were significantly reduced, to 41.3 mg/dl and 33.95 mg/dl, respectively. In subgroup analyses, total cholesterol and LDL cholesterol were significantly decreased, to 63 mg/dl and 54.6 mg/dl, respectively. Liver and kidney function showed no significant difference after taking Daeshiho-tang. Conclusions: Daeshiho-tang as a decoction or powder had significant lipid-lowering effects on total cholesterol and LDL cholesterol in patients with dyslipidemia. The lipid-lowering effect on total and LDL cholesterol increased in patients with hypercholesterolemia and hyper-LDL-cholesterolemia, respectively. Based on the minimal changes in the liver and kidney function test, Daeshiho-tang would be safe enough to be used in clinics.

참고문헌 (28)

  1. 한국지질동맥경화학회진료지침위원회, "이상지질 혈증 치료지침", pp.5~28 (2018), 도서출판 아카데미아
  2. 2016국민건강통계 I, 국민건강영양조사 제 7기 1차년도(2016), "보건복지부 질병관리본부", 질병관리본부, ~ (2017)
  3. 이세라, "의약품부작용보고시스템 데이터베이스를 이용한 고강도 statin과 중·저강도 statin 관련 이상사례 비교 분석", 한국임상약학회지, 28(4), pp.293~299 (2018), 한국임상약학회[DOI]
  4. Maningat P, "How do we improve patient compliance and adherence to long-term statin therapy?", Current Atherosclerosis Reports, 15(1), pp.291~ (2013)
  5. 이장천, "시호 추출물이 고지방식이를 급여 한 흰쥐의 혈청지질 및 항산화계에 미치는 영향", 대한한의학방제학회지, 11(1), pp.151~159 (2003)
  6. Kim KS, "A Study on the Inhibitory Effects of Scutellariae Radix on Fat Accumulation", Korea Journal Oriental Medicine, 9(2), pp.45~54 (2003)
  7. 이영종, "대황 전탕액 분획이 고지방식이 투여 흰 쥐의 혈중 지질 함량에 미치는 영향", 대한본초학 회지, 15(2), pp.1229~1276 (2000)
  8. 양형길, "Rhei Rhizoma and Chunghyuldan Inhibit Pancreatic Lipase", Natural Product Sciences, 9(1), pp.38~43 (2003), 한국생약학회
  9. 이정민, "작약(Paeonia lactiflora Pall.)씨 추출물이 고콜레스테롤 흰쥐 간조직의 항산화계와 지질과산화물에 미치는 영향", Journal of Nutrition and Health, 36(8), pp.793~800 (2003), 한국영양학회
  10. 권태우, "오미자 부탄올 분획물이 고지혈증이 유도된 생쥐의 지질대사 및 간조직 유전자 발현에 미치는 영향", 대한한방내과학회지, 39(6), pp.1225~1243 (2018), 대한한방내과학회
  11. 박성혜, "인삼부산물 추출액의 ginsenosides 함량 및 고지방 식이에 있어 혈청 콜레스테롤 농도 개선에 미치는 효과", 동의생리병리학회지, 19(2), pp.459~465 (2005), 한의병리학회
  12. 박성운, "고지방식이유도 실험용 Rat에서 Statin 및 한약 2종(후박, 하수오) 투여에 따른 혈중 지질, 조직 변화 비교 연구", 대한한방내과학회지, 38(3), pp.327~335 (2017), 대한한방내과학회
  13. 이재휘, "雙降湯이 高cholesterol 食餌로 誘發된 高脂血症 白鼠에 미치는 影響", 대한한방내과학회지, 29(2), pp.432~442 (2008), 대한한방내과학회
  14. Kim BC, "The Experimental Study on the Effects of Dansamyeum on Hyperlipidemia", Korean J Oriental Int Med, 21(1), pp.126~134 (2000)
  15. 정승희, "비만유도 흰쥐에 대한 방풍통성산가미방 (防風通聖散加味方)의항고지혈 효과 및 항산화 효과", 생약학회지, 37(3), pp.190~195 (2006), 한국생약학회
  16. Kang SY, "The Experimental Study on the Effect of Chungsanggyuntong-tang on Hyperlipidemia", Korean J Oriental Int Med, 21(3), pp.409~416 (2000)
  17. Kim MN, "Comparing high-intensity versus low-to moderate-intensity statin therapy in Korean patients with acute myocardial infarction", J Lipid Atheroscler, 3(2), pp.97~104 (2014)
  18. 김상현, "스타틴과 당뇨병 발생 위험", 대한의사협회지, 60(11), pp.901~911 (2017), 대한의사협회[DOI]
  19. Jones PH, "Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources;a retrospective analysis", JAHA, 1(6), pp.e001800~ (2012)
  20. 蔡仁植, "傷寒論譯詮", pp.86~ (1995), 高文社
  21. Hee Jung, "Effects of Daeshihotang -sosonggitang-gagambang on liver injury or rats induced ccl4 and d-galactosamine", Korean J Orient Int Med, 21(2), pp.267~274 (2000)
  22. Kim Y, "Antiinflammatory effect of Daesiho, a Korean traditional prescription for cerebral infarct patients", Phytother Res, 22(6), pp.829~835 (2008)
  23. Kim CH, "The preventive effect of Daeshiho-tang on liver damage induced by acetaminophen in the rats", Korean J Orien Med Prescription, 12(2), pp.139~154 (2004)
  24. 여운홍, "大柴胡湯이 고혈압과 수축혈관에 미치는 영향", 동의생리병리학회지, 19(6), pp.1573~1579 (2005), 한의병리학회
  25. Park CS, "A Experimental Study on the Effect of Kami-Daesihotang on Hyperlipidemia &Hypertension", J Int Korean Med, 19(2), pp.159~184 (1998)
  26. 송미영, "고지방 식이 유도 비만에 대한 대시호탕 추출물의 억제 효과", 한방재활의학과학회지, 18(3), pp.41~49 (2008), 한방재활의학과학회
  27. 최혜민, "대시호탕의 새로운 제형이 3T3-L1에서 지방세포 증식과 분화 과정에 미치는 영향", 대한본초학회지, 33(2), pp.69~77 (2018), 대한본초학회[DOI]
  28. Hussain A, "Daesiho-Tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota", PLoS One, 11(11), pp.e0165483~ (2016)

관련 논문AI추천

이 간행물의 다른 논문 (29건)